Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis , HIV and malaria .

http://www.news-medical.net/news/20130507/Aeras-receives-grant-to-support-the-development-of-vaccines-against-TB-HIV-and-malaria.aspx